A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Active, not recruitingOBSERVATIONAL
Enrollment

2,907

Participants

Timeline

Start Date

February 21, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Breast Cancer
Interventions
DRUG

Bevacizumab

Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.

DRUG

Trastuzumab

Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.

DRUG

Ado-trastuzumab emtamsine

Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.

DRUG

Pertuzumab

Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.

DRUG

Atezolizumab

Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.

DRUG

Capecitabine

Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.

Trial Locations (30)

1426

Instituto Alexander Fleming, Buenos Aires

5000

Instituto Oncologico De Cordoba, Córdoba

5016

Hospital Privado Centro Medico de Cordoba, Córdoba

10150

Instituto de Oncologia Dr. Heriberto Pieter, Santo Domingo

10300

Hospital Hermanos Ameijeiras, La Habana

14080

Instituto Nacional de Cancerologia, Mexico City

15038

Instituto Nacional de Enfermedades Neoplasicas, Lima

50180

Centro Oncologico Estatal ISSEMYM, Toluca

4781151

Hospital Dr. Hernan Henriquez Aravena, Temuco

7591046

Clinica Las Condes, Santiago

8380000

Instituto Nacional del Cancer, Santiago

Unknown

Hospital de Morón, Morón

Organización Clínica Bonnadona Prevenir S.A.S, Barranquilla

Inst. Nacional de Cancerologia, Bogotá

Fundacion Cardiovascular de Colombia - Instituto del Corazón, Floridablanca

Centro Medico Imbanaco, Santiago de Cali

Hospital Zambrano Hellion TecSalud, Monterrey

Aliada Centro Oncologico, Lima

Sanatorio CASMU, Montevideo

S2000KZE

Instituto de Oncología de Rosario, Rosario

S2000ORE

Sanatorio de la Mujer, Rosario

60336-550

Crio - Centro Regional Integrado de Oncologia, Fortaleza

86015-520

Hospital do Câncer de Londrina, Londrina

27251-260

Hospital Jardim Amália, Volta Redonda

95020-450

Inst. de Vita, Caxias do Sul

90840-440

Centro de Pesquisa em Oncologia, Porto Alegre

20560-120

Instituto Nacional de Cancer - INCa, Rio de Janeiro

03102-002

Instituto Brasileiro De Controle Do Câncer - IBCC, São Paulo

01015

Grupo Angeles, Guatemala City

Lima 41

Clinica Internacional, Sede San Borja, Lima

All Listed Sponsors
collaborator

Latin American Cooperative Oncology Group

OTHER

lead

Hoffmann-La Roche

INDUSTRY